Amgen's (AMGN) OTEZLA Significantly Improved Measures Of Disease Severity In Adults With Mild-To-Moderate Plaque Psoriasis

Go back to Amgen's (AMGN) OTEZLA Significantly Improved Measures Of Disease Severity In Adults With Mild-To-Moderate Plaque Psoriasis
Amgen Inc (NASDAQ: AMGN) Delayed: 385.65 +5.87 (1.55%)
Previous Close $379.78    52 Week High $176.85 
Open $378.51    52 Week Low $133.64 
Day High $386.50    P/E 58.08 
Day Low $378.51    EPS $6.64 
Volume 8,528,108